Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-27 4:26 pm Purchase | 13G | JASPER THERAPEUTICS INC NE JSPR | Avidity Partners Management LP | 760,000 5.1% | 760,000 (New Position) | View |
| 2024-02-14 6:18 pm Sale | 13G | JASPER THERAPEUTICS INC JSPR | CITADEL ADVISORS LLC | 230,620 0.2% | -3,498,450 (-93.82%) | View |
| 2024-02-14 4:18 pm Purchase | 13G | JASPER THERAPEUTICS INC NE JSPR | Qiming U.S. Healthcare Fund II L.P. | 928,964 6.2% | 928,964 (New Position) | View |
| 2024-02-14 09:41 am Sale | 13G | JASPER THERAPEUTICS INC JSPR | BIOTECHNOLOGY VALUE FUND L P | 0 0% | -9,900,000 (Position Closed) | View |
| 2024-02-12 6:00 pm Sale | 13D | JASPER THERAPEUTICS INC JSPR | Carlyle Group Inc. CG | 1,066,189 7.1% | -7,695,702 (-87.83%) | View |
| 2024-02-09 8:36 pm Purchase | 13D | JASPER THERAPEUTICS INC NE JSPR | Velan Capital Investment Management LP | 1,471,903 9.8% | 1,471,903 (New Position) | View |
| 2024-02-05 09:15 am Purchase | 13G | JASPER THERAPEUTICS INC JSPR | SPHERA FUNDS MANAGEMENT LTD. | 7,130,625 6.39% | 1,443,491 (+25.38%) | View |
| 2024-02-02 09:50 am Purchase | 13G | JASPER THERAPEUTICS INC NE JSPR | Soleus Capital Master Fund L.P. | 987,096 8.8% | 987,096 (New Position) | View |
| 2023-10-10 11:15 am Purchase | 13G | JASPER THERAPEUTICS INC JSPR | SPHERA FUNDS MANAGEMENT LTD. | 5,687,134 5.13% | 5,687,134 (New Position) | View |
| 2023-02-27 4:05 pm Unchanged | 13D | JASPER THERAPEUTICS INC JSPR | Velan Capital Investment Management LP | 11,219,036 10.2% | 0 (Unchanged) | View |
| 2023-02-14 08:26 am Purchase | 13G | JASPER THERAPEUTICS INC JSPR | CITADEL ADVISORS LLC | 3,729,070 9.9% | 47,868 (+1.30%) | View |
| 2023-02-13 4:49 pm Unchanged | 13G | JASPER THERAPEUTICS INC JSPR | ROCHE FINANCE LTD | 4,624,606 4.2% | 0 (Unchanged) | View |
| 2023-02-10 4:18 pm Sale | 13G | JASPER THERAPEUTICS INC JSPR | AMGEN INC AMGN | 1,009,929 0.9% | -1,690,071 (-62.60%) | View |
| 2023-02-06 4:43 pm Purchase | 13G | JASPER THERAPEUTICS INC JSPR | BIOTECHNOLOGY VALUE FUND L P | 9,900,000 9.1% | 9,900,000 (New Position) | View |
| 2023-01-31 4:15 pm Purchase | 13D | JASPER THERAPEUTICS INC JSPR | Carlyle Group Inc. CG | 8,761,891 8% | 3,133,333 (+55.67%) | View |
| 2023-01-30 5:01 pm Purchase | 13G | JASPER THERAPEUTICS INC JSPR | Soleus Capital Master Fund L.P. | 6,250,000 5.7% | 6,250,000 (New Position) | View |
| 2023-01-27 4:56 pm Purchase | 13G | JASPER THERAPEUTICS INC JSPR | Velan Capital Investment Management LP | 11,219,036 10.2% | 11,219,036 (New Position) | View |
| 2022-08-11 4:47 pm Purchase | 13D | JASPER THERAPEUTICS INC JSPR | Carlyle Group Inc. CG | 5,628,558 15.4% | 5,628,558 (New Position) | View |
| 2022-04-28 4:25 pm Sale | 13G | JASPER THERAPEUTICS INC JSPR | Amplitude Healthcare Holdings LLC | 1,678,281 11% | -821,719 (-32.87%) | View |
| 2022-02-14 10:29 am Unchanged | 13G | JASPER THERAPEUTICS INC JSPR | UBS OCONNOR LLC | 0 0% | 0 (Unchanged) | View |